Share to Facebook Share to Twitter More...

Sinovac Costs More But Is Less Effective Than Other Vaccines According to Data

SINOVAC VACCINE LESS EFFECTIVE – China’s leading COVID-19 vaccine, Sinovac, was found to have a 50% efficacy rate but costs more than other vaccines.

As 2021 comes to a close, several vaccine candidates against COVID-19 were developed. Among the leading brands were Pfizer and Moderna’s COVID-19 vaccines.

However, the Philippines’ Vaccine Czar emphasized that the government was prioritizing China’s Sinovac Vaccine which had a 50% efficacy rate. According to the DOST, this was acceptable as it passed the World Health Organizations’ minimum requirements.

Sinovac Costs More, Less Effective Based On Data - Vaccine Comparison

Still, with such a low efficacy rating, Sinovac is still the second-most expensive vaccine next to Moderna which showed 95% effectiveness against COVID-19.

According to an article from ABS-CBN, here are the estimated prices of vaccines inclusive of 12% vat, 10% inflation rate:

VaccineDosesTotal Price (inclusive of 12% vat, 10% inflation rate)Efficacy Rate
# Of Recipients (For P82.5B)
Astrazeneca261090%135,245,901
Novavax236695% 225,409,836
Pfizer22,37995%34,678,436
Moderna23,904-4,50494% 18,317,051 – 21,132,172
Sinovac23,62950%22,730,403
Gamaleya21,22090%67,622,950
Covavax285495%96,604,215

Thanks for reading. We aim to provide our readers with the freshest and most in-demand content. Come back next time for the latest news here on Philnews.

What do you think about this? Leave a comment below!

READ ALSO: Choosing Sinovac Is Nonsense Due To 50% Efficacy Says Solon

Share to Facebook Share to Twitter More...

comment(s) for this post "Sinovac Costs More, Less Effective Based On Data – Vaccine Comparison". Tell us what you think abut this post by leaving your comments below.

{ 0 comments… add one }

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.